Matsumoto Shinichi, Noguchi Hirofumi, Yonekawa Yukihide, Okitsu Teru, Iwanaga Yasuhiro, Liu Xiaoling, Nagata Hideo, Kobayashi Naoya, Ricordi Camillo
Transplantation Unit, Kyoto University Hospital, Diabetes Research Institute Kyoto, Shogoin, Kyoto 606-8507, Japan.
Expert Opin Biol Ther. 2006 Jan;6(1):23-37. doi: 10.1517/14712598.6.1.23.
Pancreatic islet transplantation is one of the options for treating diabetes and has been shown to improve the quality of life of severe diabetic patients. Since the Edmonton protocol was announced, islet transplantation have advanced considerably, including islet after kidney transplantation, utilisation of non-heart-beating donors, single-donor islet transplantation and living-donor islet transplantation. These advances were based on revised immunosuppression protocols, improved pancreas procurement and islet isolation methods, and enhanced islet engraftment. Further improvements are necessary to make islet transplantation a routine clinical treatment. To synergise efforts towards a cure for type 1 diabetes, a Diabetes Research Institute (DRI) Federation is currently being established to include leading diabetes research centres worldwide, including DRIs in Miami, Edmonton and Kyoto among others.
胰岛移植是治疗糖尿病的选择之一,已被证明可改善重症糖尿病患者的生活质量。自埃德蒙顿方案公布以来,胰岛移植取得了长足进展,包括肾移植后胰岛移植、非心脏跳动供体的利用、单供体胰岛移植和活体供体胰岛移植。这些进展基于修订后的免疫抑制方案、改进的胰腺获取和胰岛分离方法以及增强的胰岛植入。要使胰岛移植成为常规临床治疗,还需要进一步改进。为了协同努力治愈1型糖尿病,目前正在建立一个糖尿病研究所(DRI)联盟,纳入全球领先的糖尿病研究中心,包括迈阿密、埃德蒙顿和京都等地的糖尿病研究所等。